OCT 25, 2016 08:22 AM PDT

Surprising Gene Mutation Reveals Rare Immunodeficiency

WRITTEN BY: Kara Marker
Next-generation sequencing revealed a rare protein deficiency from an inherited genetic mutation as the cause of a severe immune disease. Until now, the gene’s role in the human immune system was unknown.
The image shows RASGRP1-dependent vesicle transport towards the immunological synapse. Image Credit: CeMM/Tatjana Hirschmugl
One 12-year-old patient is the only affected child in their family, after three of the patient’s siblings died within the first two years of life from a mysterious diseases. Beginning immediately after birth, the patient experienced serious, potentially lethal infections that his immune system couldn’t control. After examination, scientists realized he lacked the lymphocytes for the immune system to successfully mount an attack against infection.

Knowing that three siblings experienced the same disease in addition to the 12-year-old, a collaborative researcher team from CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases and the Medical University at Vienna suggested a heritable genetic trait was the cause of all four conditions. Next-generation genomic sequencing confirmed their theory.

"Our analyses of the patient's and his parents' genomes indeed confirmed that the boy's disorder had a genetic cause," explained the study’s first author, CeMM’s Elisabeth Salzer.

They found that a mutation in the gene encoding a protein called RASGPR1 was at the root of the disease; RASGPR1 is vital in the development of lymphocytes. However, the study also showed that the protein also plays role in the maintenance of the cytoskeleton, the backbone of the cell, in natural killer cells; the details of how the protein affects these lymphocytes is still unknown.

The researchers also showed that, as expected, the healthy parents and healthy siblings had just one copy of the mutation, while the affected 12-year-old had two faulty copies; clearly one mutated copy was not enough to cause the recessive disease.
Senior author Kaan Boztug and first author Elisabeth Salzer. Image Credit: CeMM/Wolfgang Däuble
Until now, RASGPR1’s role in the human immune system was unknown; a mutation that inhibited the protein had never before been reported.

The research team has already made progress in developing treatments for this disease. An FDA-approved drug called lenalidomide has been shown to reverse some of the effects caused by RASGRP1 deficiency. There’s still a long way to go, and scientists are now looking at the possibility of using gene therapy to treat the disease.

This study was recently published in the journal Nature Immunology.
 


Source: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 17, 2018
Immunology
JUL 17, 2018
Powering up the Elderly's Immune System
Use of drugs that inhibit the TORC1 pathway has bolstered the immune systems of the elderly, leading to a decrease in potentially deadly infections such as pneumonia and influenza....
AUG 31, 2018
Immunology
AUG 31, 2018
B Cells Control Connective Tissue Disorder Scleroderma
Effector and Regulatory B cells play reciprocal role in pathogenesis of scleroderma....
OCT 04, 2018
Videos
OCT 04, 2018
Why Do We Have Nightmares With a Fever?
Fever is the body’s response to a threat. When some viruses or bacteria try to enter the body, an immune response begins that can include a sharp ris...
OCT 31, 2018
Drug Discovery
OCT 31, 2018
New Drug Target For a Rare Lymphoma
The promise of immunotherapy in oncology is stronger than ever. Now, an international team of scientists and physicians from the Research Institute of the ...
NOV 07, 2018
Immunology
NOV 07, 2018
Inflammation Can Steal Your Sleep
A link between inflammation and the circadian rhythm has been determined in mouse models. High-fat-diets may be the cause....
NOV 14, 2018
Immunology
NOV 14, 2018
Stress in Youth Can Mean Depression as an Adult
A research team investigates early life stress and its relation to adult depression and anxiety...
Loading Comments...